Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017-2018

References

• British Columbia Coroners Service. 2019. Illicit Drug Toxicity Deaths in BC January 1, 2009 – June 30, 2019. Burnaby, British Columbia, Canada: Government of British Columbia, Ministry of Public Safety and Solicitor General; 2019.
   Google Scholar
• Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–1427.
   PubMedGoogle Scholar
• National Centre for Health Statistics. 2018. Health, United States, 2017: With Special Feature on Mortality. Hyattsville, MD: Centers for Disease Control and Prevention.
   Google Scholar
• Statistics Canada. 2019. Changes in Life Expectancy by Selected Causes of Death, 2017. Ottawa, Ontario: Statistics Canada.
   Google Scholar
• Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2018;1(2):e180217.
   PubMed Web of Science ®Google Scholar
• Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010–2016. JAMA. 2018;319(17):1819–1821.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Milloy M-J, Lysyshyn M, et al. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6.
   PubMed Web of Science ®Google Scholar
• Young S, Hayashi K, Kerr T, et al. Association between current opioid agonist therapy use and positive urine drug screen for fentanyl. In Conference of the College of Problems on Drug Dependence. Late-Breaking Abstract; 2019; San Antonio, Texas.
   Google Scholar
• Jones AA, Jang K, Panenka WJ, et al. Rapid change in fentanyl prevalence in a community-based, high-risk sample. JAMA Psychiatry. 2018;75(3):298–300.
   PubMed Web of Science ®Google Scholar
• Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107–116.
   PubMed Web of Science ®Google Scholar
• Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'. Int J Drug Policy. 2017;46:146–155.
   PubMed Web of Science ®Google Scholar
• Daniulaityte R, Carlson RR, Juhascik MP, Strayer KE, Sizemore IE. Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology. Int J Drug Policy. 2019;71:3–9.
   PubMed Web of Science ®Google Scholar
• Mayer S, Boyd J, Collins A, Kennedy MC, Fairbairn N, McNeil R. Characterizing fentanyl-related overdoses and implications for overdose response: findings from a rapid ethnographic study in Vancouver, Canada. Drug Alcohol Depend. 2018;193:69–74.
   PubMed Web of Science ®Google Scholar
• Moallef S, Nosova E, Milloy MJ, et al. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver, Canada. Public Health Rep. 2019;134(4):423–431.
   PubMed Web of Science ®Google Scholar
• Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):26.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Salomone A, Bigiarini R, Vincenti M, Acosta P, Tofighi B. Testing hair for fentanyl exposure: a method to inform harm reduction behavior among individuals who use heroin. Am J Drug Alcohol Abuse. 2019;45(1):90–96.
   PubMed Web of Science ®Google Scholar
• Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122–128.
   PubMed Web of Science ®Google Scholar
• Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JA. Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia. Harm Reduct J. 2015;12(1):54.
   PubMedGoogle Scholar
• Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J. 2018;15(1):34.
   PubMedGoogle Scholar
• Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin and methamphetamine injection: an emerging drug use pattern. Subst Use Misuse. 2017;52(8):1051–1058.
   PubMed Web of Science ®Google Scholar
• Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Hadland SE, Barocas JA. Incidence and characteristics of nonfatal opioid overdose among youths aged 11 to 24 years by sex. JAMA Netw Open. 2020;3(12):e2030201.
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45.
   PubMed Web of Science ®Google Scholar
• Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay area, 1998–1999. Am J Public Health. 2001;91(11):1842–1846.
   PubMed Web of Science ®Google Scholar
• Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145.
   PubMed Web of Science ®Google Scholar
• British Columbia Coroners Service. Fentanyl-Detected Illicit Drug Toxicity Deaths January 1, 2012 to June 30, 2019. Burnaby, British Columbia, Canada: Government of British Columbia, Ministry of Public Safety and Solicitor General; 2019.
   Google Scholar
• Cheng T, Small W, Dong H, Nosova E, Hayashi K, DeBeck K. An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver. Subst Abuse Treat Prev Policy. 2018;13(1):41.
   PubMedGoogle Scholar
• Milloy MJ, Kerr T, Salters K, et al. Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis. BMC Infect Dis. 2013;13:565.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Ross J, Trew M, et al. Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline. CMAJ. 2019;191(38):E1049–E1056.
   PubMed Web of Science ®Google Scholar
• Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Drug Alcohol Depend. 2019;204:107547.
   PubMed Web of Science ®Google Scholar
• Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14–20.
   PubMed Web of Science ®Google Scholar
• Strickland JC, Havens JR, Stoops WW. A nationally representative analysis of “twin epidemics”: rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019;204:107592.
   PubMed Web of Science ®Google Scholar
• British Columbia Coroners Service. Illicit drug deaths with methamphetamine involved 2008–2017. Government of British Columbia, Ministry of Public Safety and Solicitor General; 2019.
   Google Scholar
• Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug overdose deaths involving cocaine and psychostimulants with abuse potential – United States, 2003–2017. MMWR Morb Mortal Wkly Rep. 2019;68(17):388–395.
   PubMed Web of Science ®Google Scholar
• Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242–245.
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes E, Brissette S, Marsh DC, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361(8):777–786.
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes E, Guh D, Brissette S, et al. Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial. JAMA Psychiatry. 2016;73(5):447–455.
   PubMed Web of Science ®Google Scholar
• Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253–258.
   PubMed Web of Science ®Google Scholar